JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
RNA Research Solutions

RNA Research Solutions

R1032 EZ Cap™ Mouse p53 mRNA

Summary: Mouse p53 mRNA with Cap 1 structure, providing high transcriptional efficiency
R1033 EZ Cap™ Mouse p53 mRNA (ψUTP)

Summary: Mouse p53 mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
R1034 EZ Cap™ Mouse p53 mRNA (5-moUTP)

Summary: Mouse p53 mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
K1422 HyperScribe™ T7 siRNA Synthesis Kit

Summary: dsRNA synthesis kit for RNAi experiments
B8823 Cy5.5-UTP

Summary: Uridine triphosphate modified with fluorescent dye Cy5.5 for RNA labeling

Soluble in DMSO
R1080 EZ Cap™ Mouse GM-CSF mRNA (m1Ψ)

Summary: Mouse GM-CSF mRNA with Cap 1 structure, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
R1102 EZ Cap™ EYFP mRNA (m1Ψ)

Summary: Enhanced Yellow Fluorescent Protein (EYFP) mRNA with Cap 1 structure, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
R1103 EZ Cap™ mOrange mRNA (m1Ψ)

Summary: Orange Fluorescent Protein (mOrange) mRNA with Cap 1 structure, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
R1104 EZ Cap™ tdTomato mRNA (m1Ψ)

Summary: Red Fluorescent Protein (tdTomato) mRNA with Cap 1 structure, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
M2012 DMG-PEG2000-N3

Summary: PEG modified phospholipids for liposome delivery

≥50.7 mg/mL